Pronóstico del mercado de subcontratación de asuntos regulatorios de atención médica en Oriente Medio y África hasta 2028: impacto de COVID-19 y análisis regional por tipo de servicio (desarrollo de estrategias científicas y regulatorias, redacción médica y científica, eCTD y presentaciones electrónicas, servicios de gestión de datos, servicios de gestión del ciclo de vida, Servicios de farmacovigilancia, fabricación y controles químicos (CMC), etiquetado reglamentario y servicios de ilustraciones reglamentarias) y usuario final (empresas farmacéuticas, empresas de biotecnología y empresas de dispositivos médicos)
Introducción al mercado
Oriente Medio y Asia África se compone de tres países principales: Emiratos Árabes Unidos (EAU), Arabia Saudita y Sudáfrica. Se espera un crecimiento del mercado debido al aumento del gasto en I+D. Por lo tanto, las presiones de depreciación están alimentando la tendencia a la subcontratación regulatoria. Además, las organizaciones de análisis de contratos brindan soluciones rentables y cumplen con los requisitos de las autoridades sanitarias, cambios en los escenarios de reembolso y presiones y desarrollos de precios por parte de los participantes del mercado en tecnología de subcontratación médica en países como Arabia Saudita, los Emiratos Árabes Unidos y Sudáfrica. Los países están desarrollando sus instalaciones de salud, invirtiendo fuertemente en la investigación de nuevas terapias farmacológicas y es probable que el aumento de las asociaciones con empresas extranjeras impulse el crecimiento del mercado durante el período previsto. Las crecientes actividades de consolidación del mercado son el factor principal que impulsa el crecimiento del mercado de subcontratación de asuntos regulatorios de atención médica de MEA.
El COVID-19 ha tenido graves efectos en Sudáfrica, Israel, los Emiratos Árabes Unidos y Arabia Saudita, entre otros países. en Medio Oriente y África. La pandemia ha aumentado la demanda de dispositivos médicos para atención domiciliaria. La región está presenciando un aumento en el número de pacientes ingresados en unidades de cuidados intensivos (UCI), un número cada vez mayor de medicamentos que plantean múltiples desafíos diagnósticos y terapéuticos a los sistemas de salud sobrecargados, lo que lleva a un aumento de dispositivos médicos. Oriente Medio y África, al igual que las demás regiones, también experimentaron tres oleadas de la pandemia. Dado que la pandemia aún no ha terminado, los gobiernos deben tomar medidas para evitar su propagación, proteger a los hospitales de los atascos de tráfico y garantizar una atención sin concesiones para todos los pacientes. Los países de la región MEA han tomado estrictas medidas de precaución para controlar la propagación de COVID-19. Países como los Emiratos Árabes Unidos, Arabia Saudita, Jordania, Irak e Irán han impuesto bloqueos estrictos. El mercado farmacéutico experimenta diferentes dinámicas en los diferentes países MENA. Por ejemplo, el alto poder adquisitivo y la predilección cultural por las costosas marcas extranjeras en Arabia Saudita los obligan a importar un gran porcentaje (85%) de productos farmacéuticos. La inclinación de Sudáfrica hacia los genéricos ha aumentado en los últimos años. Además, es probable que varias empresas de atención médica recurran a más asesoramiento regulatorio durante la fase de recuperación, pospandemia, centrándose especialmente en la monitorización remota, la telemedicina, la protección de datos, etc. Además, con el creciente énfasis en acelerar el desarrollo de productos y obtener aprobaciones rápidas para terapias, vacunas y dispositivos eficaces contra el COVID-19, es probable que las empresas trabajen aún más estrechamente con los reguladores. Las cuestiones médicas desempeñan un papel central a la hora de superar las barreras de acceso a los profesionales de la salud (PS). Además, debido a los requisitos de cumplimiento, Asuntos Médicos es responsable de proporcionar a los profesionales sanitarios de MEA información médica imparcial y transparente en tiempo real.
Descripción general y dinámica del mercado
Se espera que el mercado de subcontratación de asuntos regulatorios de atención médica en MEA crezca de 291,72 millones de dólares en 2021 a 538,37 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 9,1% de 2021 a 2028. Las funciones de subcontratación de asuntos regulatorios de atención médica se han vuelto desafiantes en todo el mundo. La creciente demanda para obtener aprobación para nuevos productos, centrarse más en las fortalezas centrales con un costo operativo mínimo y mantener el cumplimiento ha aumentado durante la última década. Los procesos de aprobación regulatoria de atención médica se han vuelto más estrictos y los actores del mercado consumen mucho tiempo y se esfuerzan por obtener la aprobación para su producto en el primer intento de adquirir mayores cuotas de mercado. Debido al rigor de las agencias reguladoras en los países desarrollados y al panorama regulatorio en constante cambio en los países en desarrollo, las empresas se ven obligadas a iniciar un departamento regulatorio interno o optan por subcontratar las actividades regulatorias. No es una opción viable establecer un departamento interno de asuntos regulatorios para la mayoría de las empresas de atención médica, ya que aumentaría los costos operativos y disminuiría los ingresos; por lo tanto, las empresas están adoptando cada vez más un modelo de subcontratación basado en el tamaño y la prioridad de los proyectos. Posteriormente, las inversiones en los sistemas de información regulatoria han aumentado significativamente para mantenerse al día con la necesidad de automatizar actividades como la publicación y las operaciones regulatorias. En tal escenario, la subcontratación se ha convertido constantemente en una parte importante de los asuntos regulatorios de atención médica, lo que se espera que aumente la demanda de subcontratación de asuntos regulatorios de atención médica, impulsando así el crecimiento del mercado.
Mercado clave Segmentos
El mercado de subcontratación de asuntos regulatorios de atención médica de MEA se ha segmentado según el tipo de servicio, el usuario final y el país. Según el tipo de servicio, el mercado de subcontratación de asuntos regulatorios de atención médica de MEA se segmenta en servicios médicos y de salud. redacción científica, farmacovigilancia, servicios de gestión de datos, servicios de gestión del ciclo de vida, eCTD y presentaciones electrónicas, desarrollo de estrategias científicas y regulatorias, servicios de fabricación y controles químicos (CMC), etiquetado regulatorio y servicios de arte regulatorio. El médico y El segmento de redacción científica dominó el mercado en 2020 y se espera que el segmento de farmacovigilancia sea el de más rápido crecimiento durante el período de pronóstico. Según el usuario final, el mercado se segmenta en empresas farmacéuticas, empresas de biotecnología y empresas de dispositivos médicos. El segmento de empresas farmacéuticas dominó el mercado en 2020 y se espera que sea el de más rápido crecimiento durante el período previsto. Asimismo, las empresas de dispositivos médicos segmentadas se clasifican en materiales y materiales para dispositivos médicos. biomateriales, dispositivos médicos, biomarcadores y diagnóstico in vitro (IVD), software de dispositivos médicos (SaMD), electromecánica de dispositivos médicos, dispositivos médicos basados en sustancias y dispositivos médicos de productos combinados.
Principales fuentes y empresas enumeradas
Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de subcontratación de asuntos regulatorios de atención médica en MEA son sitios web de empresas, informes anuales, finanzas informes, documentos del gobierno nacional y base de datos estadísticos, entre otros. Las principales empresas que figuran en el informe son Ariello Ireland Ltd., IQVIA Inc., PAREXEL INTERNATIONAL CORPORATION, PHARMALEX GMBH y ProductLife Group, entre otras.
Informe de razones para comprar
- Comprender el panorama del mercado de subcontratación de asuntos regulatorios de atención médica de MEA e identificar segmentos de mercado que tienen más probabilidades de garantizar un fuerte retorno
- Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado de subcontratación de asuntos regulatorios de atención médica de MEA
- Planifique eficientemente fusiones y adquisiciones y asociaciones trata en el mercado de subcontratación de asuntos regulatorios de atención médica de MEA mediante la identificación de segmentos de mercado con las ventas probables más prometedoras
- Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos del mercado de subcontratación de asuntos regulatorios de atención médica de MEA
- Obtener pronóstico de ingresos de mercado para varios segmentos de 2021 a 2028 en la región MEA.
Regulatorio de atención médica de MEA Segmentación del mercado de subcontratación de asuntos regulatorios
Mercado de subcontratación de asuntos regulatorios de atención médica de MEA: por tipo de servicio
- Médico y médico Redacción científica
- Farmacovigilancia
- Servicios de gestión de datos
- Servicios de gestión del ciclo de vida
- eCTD y presentaciones electrónicas
- Desarrollo de estrategias regulatorias y científicas
- Servicios de controles y fabricación química (CMC)
- Etiquetado regulatorio
- Servicios de arte regulatorio
Mercado de subcontratación de asuntos regulatorios de atención médica de MEA: por usuario final
- Empresas farmacéuticas
- Empresas de biotecnología
- Empresas de dispositivos médicos
- Materiales y materiales para dispositivos médicos Biomateriales
- Biomarcadores de dispositivos médicos y diagnóstico in vitro (IVD)
- Software de dispositivos médicos (SaMD)
- Electromecánica de dispositivos médicos
- Dispositivo médico Dispositivo médico basado en sustancias
- Producto combinado
Mercado de subcontratación de asuntos regulatorios de atención médica de MEA, por país
- Arabia Saudita
- Sudáfrica
- EAU
- Resto de MEA
Mercado de subcontratación de asuntos regulatorios de atención médica de MEA:Perfiles de la empresa
- Arriello Ireland Ltd.
- IQVIA Inc.
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- ProductLife Group
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Healthcare Regulatory Affairs Outsourcing Market – By Service Type
1.3.2 MEA Healthcare Regulatory Affairs Outsourcing Market – By End User
1.3.3 MEA Healthcare Regulatory Affairs Outsourcing Market – By Country
2. MEA Healthcare Regulatory Affairs Outsourcing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Healthcare Regulatory Affairs Outsourcing Market – Market Landscape
4.1 Overview
4.1.1 Middle East And Africa– PEST Analysis
4.2 Expert Opinions
5. MEA Healthcare Regulatory Affairs Outsourcing Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Regulatory Pressure on Healthcare Companies
5.1.2 Intensified Demand for Speedy Approval of New Products
5.2 Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Progress in Specialty Therapies, Orphan Drugs, and Personalized Medicines
5.4 Future Trends
5.4.1 Soaring Market Consolidation Activities
5.5 Impact Analysis
6. Healthcare Regulatory Affairs Outsourcing Market – MEA Analysis
6.1 MEA Healthcare Regulatory Affairs Outsourcing Market Revenue Forecast and Analysis
7. MEA Healthcare Regulatory Affairs Outsourcing Market Analysis – By Service Type
7.1 Overview
7.2 Healthcare Regulatory Affairs Outsourcing Market, by Service Type (2021 and 2028)
7.3 Regulatory and Scientific Strategy Development
7.3.1 Overview
7.3.2 Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Medical and Scientific Writing
7.4.1 Overview
7.4.2 Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.5 eCTD and E-Submissions
7.5.1 Overview
7.5.2 eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Data Management Services
7.6.1 Overview
7.6.2 Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Life Cycle Management Services
7.7.1 Overview
7.7.2 Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Pharmacovigilance
7.8.1 Overview
7.8.2 Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Chemistry Manufacturing and Controls (CMC) Services
7.9.1 Overview
7.9.2 Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Regulatory Labelling
7.10.1 Overview
7.10.2 Regulatory Labelling : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.11 Regulatory Artwork Services
7.11.1 Overview
7.11.2 Regulatory Artwork Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8. MEA Healthcare Regulatory Affairs Outsourcing Market Analysis – By End User
8.1 Overview
8.2 Healthcare Regulatory Affairs Outsourcing Market, by End-User (2020 and 2028)
8.3 Pharmaceutical Companies
8.3.1 Overview
8.3.2 Pharmaceutical Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Biotechnology Companies
8.4.1 Overview
8.4.2 Biotechnology Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Medical Device Companies
8.5.1 Overview
8.5.2 Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5.2.1 Medical Device Software (SaMD) Market
8.5.2.1.1 Overview
8.5.2.1.2 Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.2 Medical Device Materials & Biomaterials Market
8.5.2.2.1 Overview
8.5.2.2.2 Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.3 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market
8.5.2.3.1 Overview
8.5.2.3.2 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.4 Medical Device Electro mechanics Market
8.5.2.4.1 Overview
8.5.2.4.2 Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.5 Medical Device Substance Based Market
8.5.2.5.1 Overview
8.5.2.5.2 Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.6 Medical Device of Combination Product (DDC) Market
8.5.2.6.1 Overview
8.5.2.6.2 Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
9. MEA Healthcare Regulatory Affairs Outsourcing Market – Country Analysis
9.1 Overview
9.1.1 Middle East & Africa: Healthcare Regulatory Affairs Outsourcing Market, by Country, 2021 & 2028 (%)
9.1.1.1 Saudi Arabia: Healthcare Regulatory Affairs Outsourcing Market - Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 Saudi Arabia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 Saudi Arabia Healthcare Regulatory Affairs Outsourcing Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3 Saudi Arabia: Healthcare Regulatory Affairs Outsourcing Market, by End User – 2019–2028 (USD Million)
9.1.1.1.3.1 Saudi Arabia: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.2 UAE: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 UAE: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 UAE Healthcare Regulatory Affairs Outsourcing Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3 UAE: Healthcare Regulatory Affairs Outsourcing Market, by End User – 2019–2028 (USD Million)
9.1.1.2.3.1 UAE: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.3 South Africa: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 South Africa: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 South Africa Healthcare Regulatory Affairs Outsourcing Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3 South Africa: Healthcare Regulatory Affairs Outsourcing Market, by End User – 2019–2028 (USD Million)
9.1.1.3.3.1 South Africa: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.4 Rest of Middle East and Africa: Healthcare Regulatory Affairs Outsourcing Market - Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Rest of Middle East and Africa: Healthcare Regulatory Affairs Outsourcing Market - Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Rest of Middle East & Africa Healthcare Regulatory Affairs Outsourcing Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3 Rest of Middle East & Africa: Healthcare Regulatory Affairs Outsourcing Market, by End User – 2019–2028 (USD Million)
9.1.1.4.3.1 Rest of Middle East & Africa: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on MEA Healthcare Regulatory Affairs Outsourcing Market
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Arriello Ireland Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 PAREXEL INTERNATIONAL CORPORATION
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 IQVIA Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PHARMALEX GMBH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 ProductLife Group
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. MEA Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia Healthcare Regulatory Affairs Outsourcing Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Healthcare Regulatory Affairs Outsourcing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies – Revenue and Forecast to 2028 (USD Million)
Table 5. UAE Healthcare Regulatory Affairs Outsourcing Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Healthcare Regulatory Affairs Outsourcing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies – Revenue and Forecast to 2028 (USD Million)
Table 8. South Africa Healthcare Regulatory Affairs Outsourcing Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 9. South Africa Healthcare Regulatory Affairs Outsourcing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of Middle East & Africa Healthcare Regulatory Affairs Outsourcing Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of Middle East & Africa Healthcare Regulatory Affairs Outsourcing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of Middle East & Africa Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies – Revenue and Forecast to 2028 (USD Million)
Table 14. Organic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 15. Inorganic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 16. Glossary of Terms, MEA Healthcare Regulatory Affairs Outsourcing Market
LIST OF FIGURES
Figure 1. MEA Healthcare Regulatory Affairs Outsourcing Market Segmentation
Figure 2. MEA Healthcare Regulatory Affairs Outsourcing Market Segmentation, By Country
Figure 3. MEA Healthcare Regulatory Affairs Outsourcing Market Overview
Figure 4. Medical & Scientific Writing Segment Held the Largest Share of the Service Type Segment in MEA Healthcare Regulatory Affairs Outsourcing Market
Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period
Figure 6. Middle East and Africa PEST Analysis
Figure 7. MEA Healthcare Regulatory Affairs Outsourcing Market Impact Analysis of Driver and Restraints
Figure 8. MEA Healthcare Regulatory Affairs Outsourcing Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. MEA Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by Service Type (2020 and 2028)
Figure 10. MEA Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. MEA Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. MEA eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. MEA Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. MEA Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. MEA Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. MEA Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. MEA Regulatory Labelling: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. MEA Regulatory Artwork Services : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. MEA Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by End-User (2020 and 2028)
Figure 20. MEA Pharmaceutical Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. MEA Biotechnology Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. MEA Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. MEA Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. MEA Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. MEA Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. MEA Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. MEA Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. MEA Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Middle East & Africa: Healthcare Regulatory Affairs Outsourcing Market, by Key Country – Revenue (2021) (USD Million)
Figure 30. Middle East & Africa: Healthcare Regulatory Affairs Outsourcing Market, by Country, 2021 & 2028 (%)
Figure 31. Saudi Arabia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. UAE: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. South Africa: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of Middle East and Africa: Healthcare Regulatory Affairs Outsourcing Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets- Arriello Ireland Ltd.
- IQVIA Inc.
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- ProductLife Group
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA Healthcare Regulatory Affairs Outsourcing market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the MEA Healthcare Regulatory Affairs Outsourcing market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the Healthcare Regulatory Affairs Outsourcing market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution